Microtransplantation in older patients with AML: A pilot study of safety, efficacy and immunologic effects

scientific article published on 12 March 2020

Microtransplantation in older patients with AML: A pilot study of safety, efficacy and immunologic effects is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/AJH.25781
P932PMC publication ID7433709
P698PubMed publication ID32162718

P50authorSharareh Siamakpour-ReihaniQ57616266
Rebecca A ShelbyQ88101626
Nelson J ChaoQ88101634
Anthony D SungQ90256782
Lauren BohannonQ91524262
David RizzieriQ92624494
Cliburn ChanQ101225189
P2093author name stringAndrew B Nixon
Vijayakrishna K Gadi
Zhiguo Li
Ahmed Galal
Harry Erba
Carlos de Castro
Hong Yuen Wong
Jichun Xie
Jing Lyu
Everett Meyer
Arati V Rao
Christopher S Hourigan
Laura W Dillon
Thomas LeBlanc
Janet Staats
Alexandra Stefanovic
Danielle Brander
Louis Diehl
Shekeab Jauhari
P2860cites workNonengraftment haploidentical cellular immunotherapy for refractory malignancies: tumor responses without chimerismQ53407174
Quantification of maternal microchimerism by HLA-specific real-time polymerase chain reaction: studies of healthy women and women with scleroderma.Q54725774
The cytokine network in acute myeloid leukemia (AML): A focus on pro- and anti-inflammatory mediatorsQ61021818
Resistance of guinea pigs to leukemia following transfer of immunocompetent allogeneic lymphoid cellsQ68759863
TREATMENT OF PRIMARY FIBROSARCOMA IN THE RAT WITH IMMUNE LYMPHOCYTESQ76846083
Reference values for the timed up and go test: a descriptive meta-analysisQ80127747
Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcomeQ82366072
Statistics review 6: Nonparametric methodsQ24807133
Statistical Considerations for Analysis of Microarray ExperimentsQ27023018
Age-related risk profile and chemotherapy dose response in acute myeloid leukemia: a study by the German Acute Myeloid Leukemia Cooperative GroupQ27851459
The prognostic value of serum C-reactive protein, ferritin, and albumin prior to allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndromesQ33573495
Recurrent expression signatures of cytokines and chemokines are present and are independently prognostic in acute myelogenous leukemia and myelodysplasiaQ33843736
Prognostic and predictive blood-based biomarkers in patients with advanced pancreatic cancer: results from CALGB80303 (Alliance)Q34447921
Age and acute myeloid leukemiaQ34564663
High-dose daunorubicin in older patients with acute myeloid leukemiaQ34612117
Impact of donor age on outcome after allogeneic hematopoietic cell transplantationQ34859147
On the assessment of the added value of new predictive biomarkersQ34878491
Implementing a Geriatric Assessment in Cooperative Group Clinical Cancer Trials: CALGB 360401Q34879258
On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia GroupQ35155166
Big data analysis of treatment patterns and outcomes among elderly acute myeloid leukemia patients in the United StatesQ35581741
The impact of comorbid disease history on all-cause and cancer-specific mortality in myeloid leukemia and myeloma - a Swedish population-based studyQ35832484
OMIP-006: phenotypic subset analysis of human T regulatory cells via polychromatic flow cytometryQ35961460
Survival for older patients with acute myeloid leukemia: a population-based studyQ36662052
Covariance estimators for generalized estimating equations (GEE) in longitudinal analysis with small samplesQ36784601
A distinct evolution of the T-cell repertoire categorizes treatment refractory gastrointestinal acute graft-versus-host diseaseQ36928351
Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD.Q37268970
MDS and secondary AML display unique patterns and abundance of aberrant DNA methylationQ37396081
Epigenetic therapy is associated with similar survival compared with intensive chemotherapy in older patients with newly diagnosed acute myeloid leukemiaQ37635209
Harnessing the power of alloreactivity without triggering graft-versus-host disease: how non-engrafting alloreactive cellular therapy might change the landscape of acute myeloid leukemia treatment.Q38250267
Identification of Interleukin-1 by Functional Screening as a Key Mediator of Cellular Expansion and Disease Progression in Acute Myeloid Leukemia.Q40268513
Influence of donor age in allogeneic stem cell transplant outcome in acute myeloid leukemia and myelodisplastic syndrome.Q40904059
Biomarker signatures correlate with clinical outcome in refractory metastatic colorectal cancer patients receiving bevacizumab and everolimusQ41391097
Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.Q43102402
Age-specific differences in oncogenic pathway dysregulation and anthracycline sensitivity in patients with acute myeloid leukemiaQ43534631
HLA-Mismatched Microtransplant in Older Patients Newly Diagnosed With Acute Myeloid Leukemia: Results From the Microtransplantation Interest GroupQ47639413
Development of an Unrelated Donor Selection Score Predictive of Survival after HCT: Donor Age Matters MostQ49904514
Do We Need Full Donor Chimerism? How Alloreactive Cell Therapies without Substantial Engraftment Might Treat Hematologic Cancers.Q51002251
HLA-Mismatched Stem-Cell Microtransplantation As Postremission Therapy for Acute Myeloid Leukemia: Long-Term Follow-UpQ51305274
Infusion of HLA-mismatched peripheral blood stem cells improves the outcome of chemotherapy for acute myeloid leukemia in elderly patientsQ51536323
P577publication date2020-03-12
P1433published inAmerican Journal of HematologyQ4744246
P1476titleMicrotransplantation in older patients with AML: A pilot study of safety, efficacy and immunologic effects

Search more.